In patients with a worsening Rio-Score at one year, expression of BMP2 was higher at baseline and six months, and that of BMP5 was increased at one month, indicating that BMP signaling is altered in MS patients [17], although its expression does not seem to be related to VD levels and did not change after serum levels returned to normal. Here, BMP5 is linked to myeloid sarcoma.